German pharmaceutical giant Bayer said it’s facing a double hit from a higher legal bill for claims relating to weed killer Roundup and €9.25 billion ($10.8 billion) in impairments on Monsanto-related agriculture businesses. According to the company, the write-downs were driven by weaker demand from farmers due to low biofuel prices and an increase of about $750 million in the costs of settlement terms with US plaintiffs over Roundup. As a result, the losses before interest and tax amounted to €9.4 billion ($10.9 billion) in the third quarter. “The impact of the (coronavirus) pandemic is placing additional strain on our Crop Science Division. We are also facing negative currency effects,” Chief Financial Officer Wolfgang Nickl said. Nickl explained that a massive depreciation of the Brazilian real was weighing heavily on the firm’s business in the world’s second-largest agricultural market.
Much of my 2025 will be devoted to co-authoring a book with my great English…
For far too long, India has evaded responsibility for its insidious practices of cross-border terrorism,…
Once bitten, twice shy, yet here we are again, staring at the barrel of a…
Over two years since I first pronounced World War 2.5, primarily due to the increasing…
Before taking a look into Voice of America's controversial journalistic standards; let's enlighten the thoughts…
In recent years, the political and media landscape in Pakistan has become increasingly muddled with…
Leave a Comment